• Who we are

Our focus

Multispecific yet natural

We strongly believe that multispecific antibodies can only meet their full potential if they are well tolerated by the human body.

Taking advantage of the unique features of human antibody light chains, we have developed an approach to generate bispecific antibodies that fully retain the sequence and architecture of human antibodies.

They are therefore ideally suited for therapeutic applications, in particular if prolonged administration to patients is required.

New publication in Frontiers

Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody


Read more

LinkedIn